[Proposal of guidelines for the set-up of pharmaco-epidemiologic studies in drug surveillance].
In the light of recent experiences and anticipating an increase in similar requests in the future, it seemed very interesting to a drug safety executives' group from the pharmaceutical industry to propose guidelines for the set-up and follow-up of pharmacoepidemiological studies requested by Health Authorities for the assessment of drug risk. The scope of these guidelines is to establish the responsibility of the teams and structures involved in the study, to define the necessary stages set-up, and to determine the rules in order to ensure its smooth running from the drafting of the protocole to the final use of the data.
de Tricornot
B
B
Département de Pharmacovigilance, Laboratoire Sanofi Wintrop, Gentilly, France.
Saddier
P
P
Bons
B
B
Clément
J P
JP
Courtand
M
M
Lamarque
V
V
Thomas
A
A
Tomczyk
S
S
Vaissère
J
J
D002986:Clinical Trials as Topic / Q000379:methods; D017408:Guidelines as Topic; D006801:Humans; D007885:Legislation, Pharmacy; D017891:Pharmacoepidemiology; D011358:Product Surveillance, Postmarketing / Q000379:methods*